These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8860280)

  • 21. Differences in predictors of cervical and breast cancer screening by screening need in uninsured Latino women.
    Buki LP; Jamison J; Anderson CJ; Cuadra AM
    Cancer; 2007 Oct; 110(7):1578-85. PubMed ID: 17696119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria.
    Vutuc C; Haidinger G; Waldhoer T; Ahmad F; Breitenecker G
    Wien Klin Wochenschr; 1999 May; 111(9):354-9. PubMed ID: 10407996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The accuracy of Pap smear utilization self-report: a methodological consideration in cervical screening research.
    Bowman JA; Redman S; Dickinson JA; Gibberd R; Sanson-Fisher RW
    Health Serv Res; 1991 Apr; 26(1):97-107. PubMed ID: 2016170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. English proficiency and physicians' recommendation of Pap smears among Hispanics.
    De Alba I; Sweningson JM
    Cancer Detect Prev; 2006; 30(3):292-6. PubMed ID: 16844320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Augmentation of Pap smear screening of high risk aboriginal women. Use of a computerised process tool within the Broome Aboriginal Medical Service.
    Couzos S; Wronski I; Murray R; Cox H
    Aust Fam Physician; 1998 Apr; 27(4):269-74. PubMed ID: 9581335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M; Daltveit AK; Thoresen SO; Nygård JF
    BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
    Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
    Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CAPRELA (Cancer Prevention for Latinas): findings of a pilot study in Winston-Salem, Forsyth County.
    Koval AE; Riganti AA; Foley KL
    N C Med J; 2006; 67(1):9-15. PubMed ID: 16550986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathways to diagnosis of cervical cancer: screening history, delay in follow up, and smear reading.
    Priest P; Sadler L; Peters J; Crengle S; Bethwaite P; Medley G; Jackson R
    BJOG; 2007 Apr; 114(4):398-407. PubMed ID: 17166215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for cervical cancer: will women accept less?
    Sirovich BE; Woloshin S; Schwartz LM
    Am J Med; 2005 Feb; 118(2):151-8. PubMed ID: 15694900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants and evolution of squamous intraepithelial lesions in HIV-infected women, 1991-2004.
    Drogoul-Vey MP; Marimoutou C; Robaglia-Schlupp A; Beerli M; Gastaut JA; Cau P; Poizot-Martin I
    AIDS Care; 2007 Sep; 19(8):1052-7. PubMed ID: 17852004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Organized cervical cancer screening for underpriviledged women].
    Piana L; Leandri FX; Jacqueme B; Heid P; Corti J; Andrac-Meyer L; Sancho-Garnier H
    Bull Cancer; 2007 May; 94(5):461-7. PubMed ID: 17535784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uptake of Pap smears among women in a large Israeli HMO between 2006 and 2008.
    Raz R; Shavit O; Stein M; Cohen R; Schejter E; Chodick G; Shalev V
    Public Health; 2012 Jul; 126(7):594-9. PubMed ID: 22657092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-reports of Pap smear screening in women with physical disabilities.
    Lin JD; Chen SF; Lin LP; Sung CL
    Res Dev Disabil; 2011; 32(2):456-61. PubMed ID: 21273042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of Pap smear and its influencing factors among women with disabilities in Taiwan.
    Huang KH; Tsai WC; Kung PT
    Res Dev Disabil; 2012; 33(2):307-14. PubMed ID: 22100350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical screening in general practice: call and recall.
    Ridsdale LL
    J R Coll Gen Pract; 1987 Jun; 37(299):257-9. PubMed ID: 3129556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.
    Lewis H; Yeh LC; Almendral B; Neal H
    N Z Med J; 2009 Oct; 122(1305):15-25. PubMed ID: 19966874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic cytological investigation for cervical cancer in relation to stage at diagnosis: a study of 420 women in Denmark.
    Olesen F
    J R Coll Gen Pract; 1988 Aug; 38(313):356-9. PubMed ID: 3256647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Case-control study of the effectiveness of mass screening in reducing invasive cervical cancer].
    Makino H; Sato S; Yajima A; Fukao A
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep; 43(9):1226-32. PubMed ID: 1919184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.